Alison Moore, Chief Technical Officer at Allogene Therapeutics, Inc. (ALLO), sold 44,574 shares at $40.00 ($1.8M) on 2020-10-06, disclosed to the SEC on 2020-10-08.
Open-market sale of $1.8M ALLO by Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALLO | SELL | 2022-03-17 | $133K | — | Filing → |
| ALLO | SELL | 2021-03-17 | $470K | — | Filing → |
| ALLO | SELL | 2020-10-13 | $1.5M | — | Filing → |